Gary D. Steinberg, MD, FACS – SAB Chairman
Gary D. Steinberg, MD, is the Professor and Director of the Goldstein Bladder Cancer Program NYU Langone Health. After receiving his medical degree from the University of Chicago Pritzker School of Medicine, he completed his internship and junior residency in surgery, as well as a residency in urology at the Johns Hopkins Hospital in Baltimore, Maryland. While at Johns Hopkins, he was an American Cancer Society clinical fellow in urologic oncology. Dr. Steinberg’s professional interests include bladder cancer and translational clinical research, which he has lectured on around the world.
Dr. Steinberg has served as the principal investigator or co-investigator on more than 45 clinical trials that evaluated pharmaceutical entities; treatment paradigms; and procedures for bladder cancer and other malignancies. He has authored or coauthored more than 200 articles in journals such as Journal of Urology, Urology, and Urologic Oncology, as well as nearly 2 dozen chapters for medical textbooks. Currently, he currently serves on the editorial board of the multiple urologic oncology journals. Dr. Steinberg is chair of the Scientific Advisory Board of the Bladder Cancer Advocacy Network, as well as of the executive committee of the Bladder Cancer Research Network. He is also a member of ASCO, the Society of Urologic Oncology, and AUA, among others. Chicago magazine named Dr. Steinberg a “Top Doctor” 10 years in a row, and U.S. News & World Report recognized him as a “Best Doctor” 7 years running. The Society of Urologic Oncology has awarded Dr. Steinberg and the University of Chicago an accreditation for Urologic Oncology Fellowship training.
For more information on Dr. Steinberg’s accomplishments, research, and practice, check out his professional page here.